Fidelity Disruptive Medicine ETF
FMED
7 hedge funds and large institutions have $33.3M invested in Fidelity Disruptive Medicine ETF in 2024 Q3 according to their latest regulatory filings, with 0 funds opening new positions, 3 increasing their positions, 1 reducing their positions, and 1 closing their positions.
200% more repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 1
9% more capital invested
Capital invested by funds: $30.6M → $33.3M (+$2.69M)
0.26% less ownership
Funds ownership: 59.96% → 59.71% (-0.26%)
13% less funds holding
Funds holding: 8 → 7 (-1)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 1
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Jane Street
New York
|
+$1.03M |
| 2 |
Wealth Enhancement Advisory Services
Plymouth,
Minnesota
|
+$486K |
| 3 |
UBS Group
Zurich,
Switzerland
|
+$15.6K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
-$1.67M |
| 2 |
DF
Dunhill Financial
London,
United Kingdom
|
-$1.38K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
Fidelity Investments
Boston,
Massachusetts
| $17.4M | -$1.67M | -66,239 | -9% |
|
|
2
Wealth Enhancement Advisory Services
Plymouth,
Minnesota
| $14.2M | +$486K | +19,240 | +4% |
|
|
3
Jane Street
New York
| $1.61M | +$1.03M | +40,924 | +200% |
|
|
4
UBS Group
Zurich,
Switzerland
| $16.9K | +$15.6K | +618 | +2,687% |
|
|
TRCT
5
Tower Research Capital (TRC)
New York
| $4.26K | – | – | – |
|
|
CPBTD
6
Central Pacific Bank - Trust Division
Honolulu,
Hawaii
| $2.55K | – | – | – |
|
|
GEA
7
Glen Eagle Advisors
Kingston,
New Jersey
| $2.37K | – | – | – |
|
|
DF
8
Dunhill Financial
London,
United Kingdom
| – | -$1.38K | -36 | Closed |
|
FMED Hedge Fund Activity: Q3 2024 in Review
7 of the 6,965 institutional investors tracked by Wall St. Rank reported a position in Fidelity Disruptive Medicine ETF (FMED) for Q3 2024, worth a combined $33.3M — up 8.8% from $30.6M a quarter earlier.
Sellers outnumbered buyers: 1 fund closed out of FMED and 0 opened new positions — a net loss of 1 holder — while 1 trimmed existing stakes and 3 added.
The largest buyer was Jane Street, adding an estimated $1.03M. The largest seller was Fidelity Investments, cutting an estimated $1.67M.
- 7 institutional investors held Fidelity Disruptive Medicine ETF (FMED) as of Q3 2024, down from 8 in Q2 2024.
- Funds reported $33.3M of Fidelity Disruptive Medicine ETF stock for Q3 2024, up 8.8% quarter-over-quarter.
- 0 funds opened new Fidelity Disruptive Medicine ETF positions in Q3 2024 and 1 closed out, a net change of -1 holder.
- The largest Fidelity Disruptive Medicine ETF buyer in Q3 2024 was Jane Street, an estimated $1.03M added.
- The largest Fidelity Disruptive Medicine ETF seller in Q3 2024 was Fidelity Investments, an estimated $1.67M sold.
Based on aggregated 13F filings for Q3 2024.